Unknown

Dataset Information

0

Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.

ABSTRACT:

SUBMITTER: Marzolini C 

PROVIDER: S-EPMC7694584 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.

Marzolini Catia C   Stader Felix F   Leuppi-Taegtmeyer Anne A   Stoeckle Marcel M   Battegay Manuel M   Sendi Parham P  

Drug safety 20201127 2

Similar Datasets

Unknown Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis.
| S-EPMC5029147 | biostudies-literature
Unknown QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.
| S-EPMC8251490 | biostudies-literature
Unknown QTc Prolongation in COVID-19 Patients Using Chloroquine.
| S-EPMC7778391 | biostudies-literature
Unknown QTc prolongation among hydroxychloroquine sulphate-treated COVID-19 patients: An observational study.
| S-EPMC7646017 | biostudies-literature
Unknown No Evidence of QTc Interval Prolongation With Baxdrostat Treatment: Concentration-QTc Modeling Assessment.
| S-EPMC12518165 | biostudies-literature
Unknown QTc prolongation in adolescents with acute alcohol intoxication.
| S-EPMC9192465 | biostudies-literature
Unknown Prevalence and Risk Factors of QTc Prolongation During Pregnancy
| S-EPMC8818739 | biostudies-literature
Unknown C-reactive Protein Elevation Is Associated With QTc Interval Prolongation in Patients Hospitalized With COVID-19.
| S-EPMC9261932 | biostudies-literature
Unknown Dying from COVID-19 in nursing homes-sex differences in symptom occurrence.
| S-EPMC8100361 | biostudies-literature
Unknown Linear mixed-effects model of QTc prolongation for olmesartan medoxomil.
| S-EPMC5049657 | biostudies-literature